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Abstract
One of the obstacles to the potential clinical utility of bioengineered skeletal muscle is its limited
force generation capacity. Since engineered muscle, unlike most native muscle tissue, is composed
of relatively short myofibers, we hypothesized that its force production and transmission would be
profoundly influenced by cell-matrix interactions. To test this hypothesis, we systematically varied
the matrix protein type (collagen I/fibrin/Matrigel) and concentration in engineered, hydrogel-
based neonatal rat skeletal muscle bundles and assessed the resulting tissue structure, generation of
contractile force, and intracellular Ca2+ handling. After two weeks of culture, the muscle bundles
consisted of highly aligned and cross-striated myofibers and exhibited standard force-length and
force-frequency relationships achieving tetanus at 40 Hz. The use of 2 mg/ml fibrin (control)
yielded isometric tetanus amplitude of 1.4±0.3 mN as compared to 0.9±0.4 mN measured in
collagen I-based bundles. Higher fibrin and Matrigel concentrations synergistically yielded further
increase in active force generation to 2.8±0.5 mN without significantly affecting passive
mechanical properties, tetanus-to-twitch ratio, and twitch kinetics. Optimized matrix composition
yielded significant cellular hypertrophy (protein/DNA ratio=11.4±4.1 vs. 6.5±1.9 μg/μg in control)
and a prolonged Ca2+ transient half-width (Ca50=232.8±33.3 vs. 101.7±19.8 ms). The use of
growth-factor-reduced Matrigel instead of standard Matrigel did not alter the obtained results
suggesting enhanced cell-matrix interactions rather than growth factor supplementation as an
underlying cause for the measured increase in contractile force. In summary, biomaterial-based
manipulation of cell-matrix interactions represents an important target for improving contractile
force generation in engineered skeletal muscle.
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Various pathological conditions such as congenital defects, traumatic injuries, surgical
ablations, or degenerative myopathies can lead to considerable loss of skeletal muscle tissue
[1-2]. Since the capacity of skeletal muscle to self-regenerate is relatively limited, structural
and functional repair of large muscle damage often requires exogenous reconstruction.
Unfortunately, current reconstructive strategies, including autologous muscle transposition
and the injection of suspended satellite cells or myoblasts, yield only modest therapeutic
outcomes due to significant donor-site morbidity as well as poor retention, survival, and
integration of grafted cells [2-3]. Recently, implantation of engineered skeletal muscle
tissues has been proposed as an alternative strategy with the potential for instant structural
repair, prolonged implant survival, and accelerated functional recovery [4-5]. For
maximized therapeutic benefit, engineered muscle tissues should recapitulate the structure of
the native muscle, i.e., contain densely packed, uniformly aligned muscle fibers enveloped
with an appropriate and well-organized extracellular matrix (ECM). In vivo, the ECM
surrounding individual myofibers, called basal lamina, consists mainly of collagen IV,
laminin, and heparin sulphate-containing proteoglycans, which, in addition to the collagen I
found in the epimysium and perimysium, provide structural integrity and enable tissue
mechanotransduction [6-7]. Moreover, cell-ECM interactions contribute to critical cellular
processes during normal muscle growth and development including myogenesis and muscle
regeneration [6,8].
The influence of skeletal muscle-derived ECM on myoblast growth and differentiation in
vitro has been recently explored in a 2-dimensional (2D) setting [9-10]. These studies
demonstrated that biomimetic muscle ECM substrates substantially increased the expression
of myogenic differentiation markers and enhanced myoblast fusion resulting in formation of
large multinucleated myotubes. In a 3-dimensional (3D) setting, naturally derived hydrogels
(e.g. collagen I, fibrin and Matrigel) have been often employed as a conducive
microenvironment for the biomimetic growth and differentiation of skeletal myoblasts
because they support: 1) high density and 3D spreading of muscle cells [11] 2)
unidirectional cell alignment through the application of geometric constraints [12] and 3)
macroscopic tissue contractions. Although these hydrogel-based muscle tissues have been
successfully engineered to contain striated and aligned myotubes [12-16], their contractile
forces have been limited to several hundred μN [15-20], i.e. one to two orders of magnitude
less than those measured in normal adult muscle. The inferior functional properties of
engineered muscle have been attributed to inadequate myotube diameter, volume density,
and/or level of functional differentiation.
In this study, we hypothesized that the composition of ECM, which surrounds embedded
muscle cells in engineered skeletal muscle, is an important determinant of the contractile
function. The rationale for this hypothesis is that significantly shorter myotube length in
engineered vs. native muscle (sub mm to mm vs. several mm to several cm) will amplify the
role that cell-matrix adhesions play in the generation and transmission of force [21-22].
Thus, the engineered muscle tissue will mainly behave as series-fibered muscles (typical of
large, nonprimate mammals) where intrafascicular in-series and in-parallel connections to
surrounding matrix and among myofibers significantly affect the total force outcome
[23-24]. Therefore, given the same cell density and alignment, the contractile function of the
engineered muscle is expected to strongly depend on the type, number, and strength of cell-
matrix adhesions, which can be varied by changing the composition and/or concentration of
surrounding ECM.
To test this hypothesis, we utilized engineered muscle tissues in the form of hydrogel-based
muscle bundles. In this well-controlled system with a linear geometry and uniform 3D cell
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alignment we explored the impact of ECM on the tissue formation and function by varying
protein type and concentration in a hydrogel matrix and measuring the resulting muscle
morphology, force production, and intracellular calcium handling.
Materials and Methods
Isolation of neonatal rat skeletal myoblasts (nSKM)
Primary skeletal myoblasts were isolated from neonatal rats as previously described [25].
Briefly, muscle tissue was dissected from the hindlimbs of 2-3 day old Sprague-Dawley rats,
trimmed of excess connective tissue, minced, and digested with 1 mg/ml collagenase type II
(Worthington, Lakewood, NJ) in Wyles solution (137mM NaCl, 5mM KCl, 21mM HEPES,
0.7mM Na2HPO4, 100mM glucose, and 0.1mg/ml BSA) for 2 hrs at 37° C. Cells were then
resuspended in growth medium (DMEM (Gibco Carlsbad, CA), 10% fetal bovine serum
(Gibco), 50 U/ml penicillin G (Gibco), 50 μg/ml streptomycin (Gibco), and 5 μg/ml
gentamicin (Gibco)) preplated for 2 hours at 37° C to enrich the myoblast fraction, and
immediately used for the assembly of bioengineered muscle bundles.
Bioengineered muscle bundle assembly and culture
The protocol for preparing engineered muscle bundles was based on a method developed by
Rhim et al [14]. Tissue molds were fabricated by longitudinally splitting a 25 mm long
section of 4.7 mm diameter silicone tubing (Nalgene, Rochester, NY) and sealing both ends
with a small piece of polydimethylsiloxane (PDMS, Dow Corning, Midland, MI). Molds
were sterilized with ethanol, submerged in 0.2% (w/v) pluronic F-127 solution for 1 hr to
prevent gel adhesion, dried with nitrogen, and placed in a standard 6-well tissue culture dish.
Velcro tabs (~4×4 mm2), which served as gel attachment sites and allowed generation of
passive longitudinal tension in the bundles, were sterilized with ethanol and secured at both
ends of the mold with stainless steel pins.
The hydrogel formulation used for engineering of muscle bundles was varied by using
different: 1) matrix protein types (collagen I (BD Franklin Lakes, NJ) or fibrinogen (Sigma,
St. Louis, MO)), 2) fibrinogen concentrations (2 mg/ml, 4 mg/ml or 6 mg/ml) and 3)
percents Matrigel (BD) (10%, 20%, or 40% of total gel volume). Additionally, bundles were
prepared with the same percent of Reduced Growth Factor Matrigel (BD) and were
compared to those made with standard Matrigel. Isolated nSKMs were mixed with cooled
fibrinogen- or neutralized (using 0.1 M NaOH) collagen-containing hydrogel solution to
yield a final concentration of 15×106 cells/ml. Thrombin (Sigma) (0.5 U per mg fibrinogen)
was added to initiate the polymerization of fibrin gels. Four hundred μl of thoroughly mixed
cell/gel solution was injected into a silicone tissue mold and incubated for 30 min at 37° C
until gelation was completed. Polymerized cell/gel bundles were then maintained in growth
medium for 5 days, then switched to low serum differentiation medium (DMEM (Gibco),
3% horse serum (Hyclone, Logan, CT), 50 U/ml penicillin G (Gibco), 50 μg/ml
streptomycin (Gibco), and 5 μg/ml gentamicin (Gibco)), and cultured until day 14. Both
growth and differentiation media were supplemented with 1 mg/ml 6-aminocaproic acid
(Sigma) to inhibit fibrin degradation by serum plasmin.
Functional assessment of bioengineered muscle bundles
On day 14 of culture, muscle bundles were removed from the silicone molds, separated from
Velcro anchors, transferred into a custom chamber, and immersed in culture medium at
36±1°C. The bundles were pinned to a fixed tissue holder at one end and to a PDMS floating
holder connected to the optical force transducer at the other end. A motorized linear actuator
(Thorlabs) controlled the position of the force transducer and length of the bundle, which
was independently recorded using a CCD camera (Imagesource) mounted on the top of the
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chamber. A pair of parallel platinum electrodes served to apply electrical stimuli and elicit
isometric muscle contractions.
After 10 min equilibration, the length of muscle bundle (L) was set to a baseline length (L0)
that generated zero passive tension. Every 2 min, the bundle was elongated by 2% L0, and a
10 ms, 3 V/mm electrical pulse was applied to induce muscle contraction (twitch). The
amplitude of the active twitch and passive tension were recorded as a function of the bundle
elongation, L/L0 (Supplemental Fig. 1A). At the bundle length, L0*, where maximum twitch
amplitude (At) was generated, the bundle was stimulated every 2 min for 1 sec at increasing
frequencies (1 to 50 Hz) until tetanus was reached (Supplemental Fig. 1B). Parameters of
single twitch including amplitude (At), the time-to-peak twitch (TPT, from onset of
electrical stimulus to time of peak twitch), and half relaxation time (RT1/2, from time of
peak twitch to 50% recovery time), parameters of tetanus including peak tetanus amplitude
(AT) and time to tetanus (from onset of electrical stimulus to time of tetanus peak), as well
as the tetanus-to-twitch ratio (TtR=AT/At) were calculated from the recorded traces
(Supplemental Fig. 1C) using custom made MATLAB program.
Specific passive tension was calculated (in kPa) by dividing the measured passive tension by
the bundle cross-sectional area (derived from bundle image assuming circular cross-section).
Muscle bundle stiffness was calculated as the linear slope of the specific passive tension
curve for both low (1.02-1.06) and high (L/L0* ± 0.02) elongations (Supplemental Fig. 1A).
Measurement of intracellular calcium transients
The bioengineered muscle bundles were incubated in serum-free medium containing 5μM
calcium sensitive dye Rhod-2 (Molecular probes, Eugene, OR) for 1hr at 37°C, followed by
1hr incubation in dye-free medium. The stained bundles were then transferred into a custom
chamber mounted on an inverted fluorescence microscope (Nikon TE2000) and perfused
with warm (36°±1°) Tyrode's solution (in mM: 135 NaCl, 5.4 KCl, 1.8 CaCl, 1 MgCl, 0.33
NaHPO, 5 HEPES, 5 glucose). Blebbistatin (5 μM) was added to inhibit contractions and
eliminate motion artifacts during recordings [26]. The stained bundles were electrically
stimulated (10 ms, 3 V/mm pulses), illuminated by green light (520±25nm) and emitted
fluorescence signals (605±30nm) were simultaneously recorded from 504 sites at 2.4 kHz
sampling rate and 75 μm resolution using a photodiode array (RedShirt Imaging). The half-
width of calcium transient (Ca50) was measured from 50% upstroke to 50% recovery and
averaged over all recording sites within the bundle using a custom Matlab software.
Histology
Muscle bundles were fixed in 4% paraformaldehyde overnight at 4°C, rinsed with
Dulbecco's phosphate-buffered solution (DPBS, Gibco), dehydrated in ethanol, and
embedded in paraffin. Specimens were longitudinally and transversely cut in 10 μm sections
and stained with hematoxylin and eosin (H&E). Image J software (NIH, Bethesda, MD) was
used to measure the thickness of the dense outer muscle tissue layer containing
longitudinally oriented myotubes as well as the average myotube diameter. These thickness
measurements served to determine the effective cross-sectional area of the muscle tissue in
the bundle, which in turn were used to calculate amplitude of active specific force (in kPa).
Immunostaining
Immunostaining was performed as previously described [12]. Briefly, muscle bundles were
fixed in 4% paraformaldehyde (PFA) overnight at 4°C, rinsed with DPBS, permeabilized
with 0.5% Triton-X in DPBS for 4 hours at 37°, and blocked with 20% chicken serum/1%
bovine serum albumin for 4 hours at 37°C. The bundles were exposed to primary antibodies
(sarcomeric α-actinin, Sigma; vimentin, Sigma; integrin α7, Santa Cruz Biotechnology)
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overnight at 4°C, followed by secondary antibodies (Alexa 488 and Alexa 594, Molecular
Probes) and/or FITC-conjugated phalloidin with nuclear dye (DAPI or propidium iodide,
Invitrogen) for 1 hour at room temperature. Images were acquired using a Zeiss confocal
microscope (LSM510, Carl Zeiss MicroImaging Inc., Thornwood, NY).
Cellular Protein/DNA Quantification
The muscle bundles were cut in two halves and their wet weights were measured. Each half
of the bundle was incubated in DPBS with 10 μg/ml bovine plasmin (Innovative Research,
Novi, MI) and 0.5 mg/ml collagenase type II for 2-4 hours at 37°C until matrix was
completely dissolved. The total cellular protein content was measured in one bundle half
using a BCA™ Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL). The other
bundle half was used for the measurement of DNA content. The genomic DNA was isolated
from the muscle bundles using a DNeasy tissue kit (Qiagen) and the DNA concentration was
measured with a spectrophotometer (NanoDrop 2000, NanoDrop products, Wilmington,
DE). The protein/DNA ratio was calculated and normalized for the measured wet-weight
ratio.
Statistics
Data are presented as mean ± SE. The difference among multiple groups was analyzed using
a repeated measure one-way ANOVA followed by post-hoc Tukey's multiple-comparison
test. The differences between two groups were analyzed using a paired value student's t-test.
Data were considered statistically significant when p < 0.05.
Results
To explore the impact of hydrogel matrix composition on engineered skeletal muscle
structure and function, we systematically assessed six types of muscle bundles made of: 1)
1.4 mg/ml collagen I with 10 % Matrigel, 2) 2 mg/ml fibrinogen with 10% Matrigel, 4 mg/
ml fibrinogen with 3) 10% Matrigel, 4) 20% Matrigel, or 5) 40% Matrigel, and 6) 6 mg/ml
fibrinogen with 10% Matrigel. Significant cell-mediated gel compaction was observed in all
muscle bundles starting in first 3 days of culture. After 2 weeks, the bundles (Fig. 1A) have
undergone different degrees of compaction depending on both the type and concentration of
matrix proteins. Starting from a diameter of 4.7 mm set by the silicon tissue mold, average
bundle diameter after 2 weeks ranged from 1.1 ± 0.08 to 2.7 ± 0.18 mm (Fig. 1B). Collagen
I-based muscle bundles had the highest degree of compaction (76.6 ± 1.6 %) and, consistent
with our previous study [12], exhibited significant rate of rupture (66% in first 5-7 days of
culture), while fibrin-based bundles remained intact even when cultured for 5 weeks (not
shown). The use of higher fibrinogen and Matrigel concentrations independently and
additively reduced the final degree of bundle compaction (Fig. 1B).
As revealed by H&E staining, the muscle bundles after two weeks of culture consisted of an
outer region with densely packed cells and a relatively acellular central core (Fig. 2A1-3).
For all matrix compositions tested, the outermost cell layer of the dense outer region
contained randomly oriented, vimentin-positive fibroblasts. Underneath this cell layer were
several layers of longitudinally oriented, multinucleated, and ubiquitously cross-striated
myotubes (Fig 2.B&C) that spanned an average depth of 34.7 ± 2.5 μm (similar for different
matrix compositions). The myotubes stained positive for laminin-specific α7 integrins [27]
(Fig 2.D white arrows) with comparable staining among different groups. As assessed from
sarcormeric α-actinin stainings, at two weeks of culture, the percent of the cross-striated
myotubes was similar (> 95%) for all hydrogel formulations (not shown).
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The engineered muscle bundles began spontaneously contracting 1-2 days after switching to
low serum differentiation media (culture day 6-7). Throughout the rest of culture,
spontaneous contractions remained spatially uncoordinated and ranged in frequency from
1-3 Hz. After two weeks, electrically stimulated muscle bundles (Supplemental movie 1)
displayed biphasic force-length and positive force-frequency relationships, characteristic of
native skeletal muscle (Supplemental Fig. 1A & B) [28]. The collagen I-based muscle
bundles exhibited the lowest isometric force of contraction with the mean peak twitch (At)
and tetanus (AT) amplitudes of 0.59 ± 0.28 mN and 0.88 ± 0.42 mN (Fig. 3A,B),
respectively, and the lowest mean tetanus-to-twitch ratio (TtR) of 1.47 ± 0.04. In fibrin-
based bundles with 10% Matrigel concentration, the increase of fibrinogen concentration
from 2 mg/ml to 6 mg/ml yielded an At increase from 0.82 ± 0.20 mN to 1.03 ± 0.24 mN
and an AT increase from 1.40 ± 0.28 mN to 1.89 ± 0.24 mN, respectively (Fig. 3A,B). The
bundles containing 6 mg/ml fibrin exhibited the highest TtR of 2.11 ± 0.25. For a constant
fibrinogen concentration of 4 mg/ml, increasing the volume percent of Matrigel from 10% to
40% yielded an independent increase in At and AT. Specifically, the muscle bundles
containing 40% Matrigel produced the largest isometric forces of contraction among all 6
groups, with an At of 1.68 ± 0.32 mN and AT of 2.84 ± 0.50 mN (Fig. 3A,B). Overall,
fibrin-based bundles generated contractile forces up to ~3 fold higher than collagen I-based
bundles suggesting a significant impact of cell-matrix interactions on active force generation
in engineered muscle tissues. In addition, the generated contractile forces scaled with bundle
diameter and, when normalized by the average cross-sectional area of the active muscle
layer, the specific forces were found to be comparable among different groups (overall
average specific At = 5.5 ± 0.6 and AT = 9.4 ± 0.7 KPa, Supplementary Fig. 2).
We further explored the effect of matrix composition on bundle contraction kinetics by
measuring time to peak twitch (TPT), half relaxation time (½RT), and time to tetanus (Fig.
4). The twitch kinetics did not significantly differ between bundles with the varying matrix
compositions and averaged for all 6 groups to TPT=58.5 ± 1.6 ms and ½RT=68.2 ± 4.7 ms
(Fig. 4). In contrast, the tetanus kinetics were significantly affected by higher concentrations
of fibrinogen and Matrigel, which yielded an increase in time to tetanus from 121.3 ± 12 ms
for bundles containing 2 mg/ml fibrin and 10% Matrigel to 246.8 ± 15 ms for those
containing 4 mg/ml and 40% Matrigel (Fig. 4).
In addition to studying active force generation in muscle bundles, we also assessed their
passive mechanical properties (Fig. 5A) by measuring changes in steady-state specific
passive tension (tissue stress) as a function of relative bundle elongation (strain). At each
elongation, the collagen I-based muscle bundle group exhibited the highest passive tension
(Fig. 5A) and stiffness (local slope of the stress-elongation curve) compared to other groups
(as shown for low and high elongation, L/L0, in Fig. 5B). All fibrin-based bundles had
comparable stiffness at low L/L0 while increasing both fibrin concentration and percent
Matrigel yielded a significantly decreased stiffness at high L/L0 (Fig. 5B). In general,
muscle bundles with higher stiffness at high L/L0 generated smaller peak twitch (not shown)
and tetanus (Fig. 5C) forces.
In order to further understand how changes in hydrogel composition affect generated
contractile force, we compared different muscle bundles with respect to their cell numbers
(total DNA content), total cellular protein expression, cell size index (protein/DNA), and
average myotube diameter. Specifically, three fibrin-based hydrogel formulations with
distinct contents of fibrin and Matrigel were studied (Fig. 6). The total cell number (DNA
content) in the muscle bundles was found to be comparable among different hydrogel
formulations (Fig. 6A). Simultaneously, the average cellular protein content in the 4 mg/ml
fibrinogen + 40% matrigel group (Fig. 6B) was increased 2.54-fold relative to other two
groups, without reaching statistical significance (p=0.16). Importantly, the cell size index
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(protein/DNA) and average myotube diameter increased significantly for increasing
concentrations of fibrin and Matrigel (Fig. 6C,D). The bundles that generated the highest
force of contraction (4 mg/ml fibrinogen + 40% Matrigel group) exhibited the largest
myotube diameter (14.0 ± 0.5 μm).
We also explored if extracellular matrix composition affected calcium handling of myotubes
by recording intracellular calcium transients at different stimulation rates (Fig 7.A). As the
stimulation rate was increased to 40 Hz, cytoplasmic calcium concentration in all bundles
increased to a constant level (Fig 7.A), which supported the generation of tetanic force.
While increase in fibrin concentration had no effect on half-width calcium transient duration
(Ca50), the use of 40% Matrigel resulted in a significantly longer Ca50 (232.8 ± 33.3 ms vs.
101 ± 11.4 and 122.4 ± 12.5) (Fig. 7B,C).
Finally, to test if the higher contractile forces in bundles with increased Matrigel
concentration were a consequence of growth factors present in Matrigel [29], we compared
functional properties of bundles made with standard vs. reduced growth factor (RGF)
Matrigel formulation (Fig. 8). We found that the amplitudes and kinetics of contractile force
in these two groups were comparable, suggesting that the changes in bundle structure and
function induced by varying hydrogel formulations could be attributed to differences in cell-
matrix interactions.
Discussion
In this study, we assessed the influence of ECM composition on the structure and function
of hydrogel-based engineered neonatal rat skeletal muscle bundles. The most important
novel findings of this study are as follows: 1) cell number, alignment, incidence of cross-
striations, and rate of spontaneous contractions in engineered muscle bundles were not
influenced by the hydrogel matrix composition, 2) the use of fibrin- vs collagen I-based
hydrogels resulted in muscle bundles with superior mechanical integrity and force
generation capacity, 3) increased hydrogel concentration of fibrin and Matrigel
synergistically augmented force generation capacity without affecting the passive
mechanical properties of the muscle bundles, and 4) increase in contractile force generation
was associated with myofiber hypertrophy and prolongation of intracellular Ca2+ transients.
The optimal matrix composition (4 mg/ml fibrin with 40% Matrigel) yielded contractile
forces (2.84 ± 0.5 mN) that to our knowledge are at least 2-3-fold higher than the maximum
force values previously reported for engineered muscle tissues [13,16-19,30].
Our studies revealed that differences in initial hydrogel composition significantly influenced
the final diameter of engineered muscle bundles without affecting the total cell number (Fig.
1B and 6A). This result could be attributed to differences in the capacity of embedded cells
(i.e., mixture of myoblasts and fibroblasts) to bind and compact hydrogel matrices (collagen
I, fibrin, Matrigel) and, potentially, to different degradation rates of fibrin when co-
polymerized with varying Matrigel concentrations. Regardless of their effect on bundle
diameter, all studied matrix compositions provided conditions necessary to support neonatal
rat skeletal myoblast survival, spreading, alignment, fusion, and attainment of significant
levels of intracellular structural differentiation characterized by a well-organized sarcomere
assembly (Fig. 2C).
Similar to previous reports [13,16], all muscle bundles in this study exhibited qualitatively
similar biphasic length-tension and monotonically increasing force-frequency relationships
characteristic of native muscle, regardless of the ECM composition. On the other hand, there
were several novel results from this study regarding ECM-dependent proprieties of
engineered muscle such as the superior contractile force generation (Fig. 3) and lower
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stiffness (Fig. 5A) for fibrin- vs. collagen I-based muscle bundles. In addition, fibrinogen
concentration did not significantly affect force amplitude, contraction kinetics, Ca2+
transient duration, or total protein and DNA (Figs. 3,4,6,7). Interestingly, of all the
conditions explored in this study, increasing the Matrigel concentration (from 10% to 40%,
with 4 mg/ml fibrin) had the highest impact on bundle force production (71.4% and 64.0%
increase in At and AT, respectively), myotube size, and Ca2+ transient duration (Figs. 3,6,7).
Regarding that Matrigel (Supplementary Table 1) contains different growth factors (e.g.
IGF-1 that is shown to enhance contractile force in engineered muscle [16-17]), we
compared the function of muscle bundles engineered using standard Matrigel vs. reduced
growth factor (RGF) Matrigel (that has decreased levels of IGF-1, PDGF and TGF-β and
unchanged concentrations of laminin, collagen IV and entacin) and found no significant
difference in isometric force amplitude or twitch and tetanus kinetics (Fig. 8). Thus, another
novel and important finding of this study was that the use of higher concentration Matrigel
improved force generation capacity of engineered muscle bundles, likely by providing more
biologically active cell adhesion sites thereby enhancing myotube-matrix interactions.
Based on these results, we propose that the observed effects of matrix composition on
engineered muscle function can be attributed to specific integrin receptors that along with
dystrophin complex mediate interaction of myotubes with surrounding endomysial matrix
and play important roles in muscle development and force transmission in vivo [27]. In
particular, laminin-binding α7β1, the dominant integrin in skeletal muscle, is highly
expressed at myotendinous junctions, intrafascicular fiber terminations, and the non-
junctional sarcolemma [24,31]. This ubiquitous membrane distribution of α7 integrin
implies the high importance of myotube-laminin interactions for lateral and longitudinal
force transmission in short non-spanning muscle fibers [23-24], such as those present in
engineered skeletal muscle. Therefore, we postulate that robust binding of myotubes to
laminin via α7 integrins (Fig 2.D) is the main mechanism for significantly improved force
generation in engineered muscle bundles with higher Matrigel concentration. In support, a
recent study showed that intramuscular or systemic injection of a laminin-111 protein in the
mdx mouse model of Duchenne muscular dystrophy upregulates α7 integrin expression,
which in turn alleviates dystrophic symptoms by stabilizing the sarcolemma and preserving
muscle integrity [32].
Similar to α7 integrins, αV integrins, capable of binding to fibrin [33], are expressed in
developing and mature myotubes [27], which may explain the positive trend in force
generation observed for the increasing fibrin concentrations (Fig. 3). In contrast to α7 and
αV integrins, collagen I-specific α2 integrins are not expressed in myoblasts or myotubes,
which never directly interact with fibrous collagen I in the native endomysium [27]. This
lack of specific myotube-collagen I interactions could contribute to lower contractile forces
measured in collagen I- vs. fibrin-based muscle bundles. On the other hand, dominant
expression of α2 integrins in fibroblasts [34] may be responsible for the largest compaction
and passive tension observed in collagen-based muscle bundles. While it is expected that
these integrin-mediated effects were mainly governed by the initial composition of hydrogel
matrix, other ECM proteins deposited by cells or adsorbed from culture serum may have
also contributed to the obtained results.
Along with the improved force transmission, enhanced cell-matrix interactions likely
contributed to the myotube hypertrophy observed in our skeletal muscle bundles (Fig. 6D).
Though much remains unknown about the cellular mechanisms involved in integrin-
mediated “outside-in” signaling, several integrins, including α7 and αV, are shown to play
important roles in triggering the events leading to myoblast migration, fusion, and myotube
differentiation [8,27,35-37]. Furthermore, load-activated integrin-mediated signaling was
proposed as an important regulator of gene expression in hypertrophying skeletal muscle
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leading to increased protein synthesis [38]. Based on these studies, a more robust cell-ECM
binding in the presence of higher Matrigel or fibrinogen content in our engineered muscle
bundles was expected to promote myotube fusion and/or augment the mechanical load
(resistance) experienced by spontaneously contracting myotubes. Both of these factors could
have led to the observed increase in myotube diameter.
An interesting finding of this study was the significant prolongation of intracellular calcium
transients in engineered muscle bundles with increased Matrigel concentration (Fig. 7B,C).
Currently, little is known about the potential role that integrin binding to ECM plays in
kinetics of intracellular Ca2+ cycling in skeletal muscle. In one study, engagement of α7
integrins with laminin has been shown to trigger transient elevations in free intracellular
Ca2+ through calreticulin mediated Ca2+ signaling [39]. Calreticulin, a Ca2+ binding protein
that associates with cytoplasmic integrin domain, is known to regulate the coupling of IP3-
sensitive Ca2+ release from intracellular stores and influx through L-type Ca2+ channels, and
may thus be one of the mediators of observed Ca2+ transient prolongation. Since the
actomyosin contraction mechanism is activated by binding of intracellular Ca2+ to troponin
[28], it is possible that prolonged Ca2+ transients may have directly contributed to the
observed slowing of tetanus kinetics (Fig. 4). This possibility will be explored in our future
studies.
While hydrogel-based engineered muscle tissues typically contain Matrigel [12,14,40-41], it
is well recognized that Matrigel will not be used in humans due to its murine origin and
potential tumorigenicity. Thus, future clinical translation would require replacement of
Matrigel with a defined combination of commercially available ECM proteins and/or
reconstituted human-derived basal lamina matrix [42]. Furthermore, although the muscle
fibroblasts embedded in a fibrin gel are expected to synthesize and secrete endogenous
extracellular matrix proteins (e.g., collagen I, elastin [43-44]), this process is relatively slow.
Consequently, the major contributor to initial myogenesis and functional differentiation of
engineered muscle will be exogenous hydrogel matrix, which needs to be carefully
customized prior to tissue culture. One potential strategy to augment bioactivity of fibrin
gels for skeletal muscle tissue engineering would be enzymatic incorporation of bioactive
peptides to engage laminin-binding integrins in muscle cells [45]. In addition, due to the
rapid degradation of fibrin in vivo, the successful clinical application of fibrin-based
engineered skeletal muscle would likely require use of potent cross-linking (e.g. genipin
[30], transglutaminase [46]) and anti-fibrinolytic (e.g. engineered aprotinin [47]) agents, or a
long-term tissue culture to permit replacement of fibrin by cell-secreted ECM.
Conclusions
In support of our initial hypothesis, we have shown that manipulating hydrogel matrix
composition (i.e., cell-matrix interactions) has the potential to significantly improve
contractile function of engineered muscle tissue, as demonstrated by a 3-fold increase in
force amplitude between collagen I-based and optimized fibrin-based bundles. Importantly,
varying hydrogel composition had a larger relative effect on contractile force generation of
engineered muscle than the previously reported manipulation of cell microRNA expression,
electrical stimulation, co-culture with neuronal cells, or growth factor supplementation. Our
results therefore imply that in addition to ultrastructural and functional maturation of
individual myofibers, biomaterial-based manipulation of cell-matrix interactions represents
another important target for improving overall contractile performance of engineered
skeletal muscle. Together with methods for successful vascularization (by use of multiple
cell types or growth factors) and innervation (by use of neurotrophic and synaptogenic
factors) upon implantation, this strategy holds potential for yielding functional skeletal
Hinds et al. Page 9













muscle substitutes capable of restoring the load-bearing function of diseased or injured
muscle.
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Refer to Web version on PubMed Central for supplementary material.
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Morphology of bioengineered skeletal muscle bundles. (A) A representative muscle bundle
shown in a silicone tissue mold. The muscle bundle was anchored at each end to pinned
Velcro® tabs. (B) Final muscle bundle diameter on culture day 14 for the 6 studied hydrogel
formulations. The hydrogel formulations contained different volume percent Matrigel (Mat
%), fibrinogen concentration (Fib mg/ml) and collagen I concentration (Col I mg/ml). Bars
show n=3 bundles per group. ‘*’, statistically significant between the indicated pairings,
p<0.05.
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Structure of bioengineered skeletal muscle bundles. (A1-3) Representative H&E stainings of
a day 14 muscle bundle showing densely packed myotubes, located in the outer bundle
region (A1), that were longitudinally oriented (A2-3). White arrow in A3 indicates visible
cross-striations. (B) Confocal stack image of a day 14 bundle. Top and right frames are front
and side views of the stack, respectively. Note that fibroblasts (red) form a single outermost
layer on the bundle surface and cover muscle layers underneath (green). (C) A
representative confocal section ~20 μm below the bundle surface shows that aligned
multinucleated myotubes exhibit ubiquitous cross-striations. (D) Typical immunostaining
for α7 integrins (green, white arrows) along myotube membrane. Panels A1-3, B, and D are
from muscle bundles with 4 mg/ml fibrinogen and 10% Matrigel, while panel C is from a
muscle bundle with 4 mg/ml fibrinogen and 40% Matrigel.
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Contractile force generation in bioengineered skeletal muscle bundles. (A,B) Peak twitch
(At) and tetanus (AT) amplitudes for the 6 studied hydrogel formulations. The nomenclature
describing hydrogel formulations is the same as shown in figure 1. Bars from left to right are
obtained from n=4, 7, 8, 7, 7, and 6 bundles per group. ‘*’, statistically significant between
the indicated pairings, p<0.05.
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Kinetics of contractile force generation in bioengineered skeletal muscle bundles. Time to
peak twitch (TPT), half-relaxation time (1/2RT), and time-to-tetanus are shown for the 6
studied hydrogel formulations. The nomenclature describing hydrogel formulations and
number of bundles per group are the same as shown in figure 3. ‘*’, statistically significant
between the indicated pairings, p<0.05.
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Passive mechanical properties of bioengineered skeletal muscle bundles. (A) Specific
passive tension (stress) as a function of bundle elongation (L/L0) shown for the 6 studied
hydrogel formulations. Note increased stress in collagen I-based vs. fibrin-based bundles.
The groups without indicated Mat% contain 10% Matrigel, while those with only indicated
% Mat contain 4 mg/ml fibrinogen. (B) Muscle bundle stiffness at high and low L/L0. The
nomenclature describing hydrogel formulations (bundle groups) is the same as shown in
figure 1. (C) Correlation between tetanus amplitude (AT) and bundle stiffness at high
elongation in all 6 studied bundle groups. Number of bundles per group is the same as in
figure 3. ‘*’, statistically significant between the indicated pairings, p<0.05.
Hinds et al. Page 17














Indices of cell number and size in fibrin-based skeletal muscle bundles. (A) Total DNA
content (index of cell number) in bundles. (B) Total cellular protein content in bundles. (C)
Cellular protein/DNA ratio (index of average cell size) in bundles. (D) Average myotube
diameter in bundles. The nomenclature describing hydrogel formulations is the same as in
figure 1. For A-C, n=4 bundles per group; For D, n=3 bundles per group. ‘*’, statistically
significant between the indicated pairings, p<0.05.
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Intracellular Ca2+ transients in fibrin-based skeletal muscle bundles. (A) Representative
optically recorded traces of intracellular Ca2+ concentration for different stimulation
frequencies. Note that increasing pacing frequency yields a sustained elevated level of
intracellular Ca2+ concentration. (B) Representative single Ca2+ transients for 3 studied
hydrogel compositions showing differences in the transient duration. (C) Half-width of the
Ca2+ transient duration (Ca50) in engineered bundles. Bars show n=3 bundles per group. The
nomenclatures describing hydrogel compositions are the same as in figure 5. ‘*’, statistically
significant between the indicated pairings, p<0.05.
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Comparison of contractile force generation in bioengineered skeletal muscle bundles made
using standard vs. reduced growth factor (RGF) Matrigel. (A) Twitch (At) and tetanus (AT)
amplitudes. (B) Kinetic parameters of twitch and tetanus, with nomenclature defined in
figure 4. Muscle bundles were made with 4 mg/ml Fibrinogen and 40% standard or RGF
Matrigel. Bars show n=3 bundles per group.
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